Info - IV Labs

What is IV Infusion Therapy?

Drugs produced by pharmaceutical companies, although sometimes necessary, are frequently associated with significant adverse side effects and can paradoxically increase the body’s toxicity unnecessarily. At IVLabs, our goal is to forego the overuse of traditional pharmaceutical drugs and instead provide patients with natural vitamins, amino acids, and mineral-based therapies which enable the body to heal itself.

Why IV Therapy?

Among the many benefits of IV infusions is complete bioavailability of the ingredients in the infusion. This simply means that 100 percent of the amino acid, mineral, or vitamin is delivered to the bloodstream of the patient.

Typically, only approximately 20% to 30% of the same amino acid, mineral or vitamin taken orally, is ultimately delivered to the bloodstream. It is the degree of delivery to the bloodstream which enables the ingredient to exert its maximum beneficial effect on the body.

Is It Safe?

The nutrients utilized in IV therapy are vitamins and minerals which are known as “Essential Nutrients” (those that our bodies must have, not just to survive, but to function at 100%) that we are unable to derive from other raw materials.

When the modern diet was invented, processed foods began to dominate the market. This has translated to a general lack of these Essential Nutrients, and an increase in chronic illness.

Though these infusions are hugely beneficial to their users, there are some small risks. Bruising may occur at the injection site – comparable to having blood drawn for a lab test. Certain side effects may include “infiltration”, which can be caused by vascular fragility and result in a rupture of the vein wall and fluid leakage into the surrounding tissue. Patients with small, difficult-to-locate veins or who are prone to vascular weakness may not be candidates for IV therapy (though it may be possible, in some instances, that administering oral nutrients in high doses can rebuild one’s nutritional state, strengthening the veins to the point that IV therapy is once again a viable option).